| 专利名称 | Pharmaceutically acceptable salts have elongated an outer water phase number number billion as potassium channel | ||
| 申请号 | KR1020187035905 | 申请日 | |
| 公开（公告）号 | KR1020190015305A | 公开（公告）日 | 2017-06-06 |
| 申请（专利权）人 | 发明人 | LU YUN; SHAO QIYUN; WU GUAILI; FENG JUN | |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
Provided is a pharmaceutically acceptable salt as a renal outer medullary potassium channel (ROMK) inhibitor, specifically an L-tartrate and a crystal form I and crystal form II thereof. The pharmaceutically acceptable salt of the ROMK inhibitor, specifically the L-tartrate, has improved bioavailability and stability. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
